REGENXBIO, Inc. (RGNX)
7.98
+0.04
(+0.44%)
USD |
NASDAQ |
Sep 16, 16:00
7.98
0.00 (0.00%)
After-Hours: 20:00
REGENXBIO Price : 7.98 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | 7.93 | 7.99 | 7.636 | 7.98 | 1.232M |
| Sep 15, 2026 | 8.69 | 8.75 | 7.78 | 7.945 | 1.427M |
| Sep 14, 2026 | 8.58 | 8.728 | 8.49 | 8.69 | 858446.0 |
| Sep 11, 2026 | 8.69 | 8.82 | 8.39 | 8.53 | 1.029M |
| Sep 10, 2026 | 8.63 | 8.79 | 8.47 | 8.56 | 1.172M |
| Sep 09, 2026 | 8.70 | 9.025 | 8.62 | 8.73 | 1.408M |
| Sep 08, 2026 | 8.95 | 8.95 | 8.60 | 8.76 | 998960.0 |
| Sep 04, 2026 | 9.09 | 9.215 | 8.86 | 8.94 | 1.071M |
| Sep 03, 2026 | 9.56 | 9.56 | 9.00 | 9.20 | 839249.0 |
| Sep 02, 2026 | 9.34 | 9.708 | 9.20 | 9.60 | 866267.0 |
| Sep 01, 2026 | 9.38 | 9.616 | 9.28 | 9.32 | 783801.0 |
| Aug 31, 2026 | 9.50 | 9.68 | 9.09 | 9.50 | 1.612M |
| Aug 28, 2026 | 10.00 | 10.10 | 9.212 | 9.66 | 1.754M |
| Aug 27, 2026 | 9.35 | 9.46 | 9.04 | 9.37 | 916586.0 |
| Aug 26, 2026 | 8.85 | 9.43 | 8.61 | 9.38 | 1.160M |
| Aug 25, 2026 | 8.14 | 8.99 | 8.13 | 8.91 | 1.757M |
| Aug 24, 2026 | 8.29 | 8.64 | 7.77 | 8.055 | 5.447M |
| Aug 21, 2026 | 11.14 | 11.16 | 10.49 | 10.72 | 1.007M |
| Aug 20, 2026 | 11.98 | 12.08 | 11.03 | 11.06 | 947369.0 |
| Aug 19, 2026 | 11.50 | 12.04 | 11.50 | 12.02 | 1.147M |
| Aug 18, 2026 | 11.13 | 11.20 | 10.73 | 11.07 | 623930.0 |
| Aug 17, 2026 | 10.69 | 11.36 | 10.53 | 11.33 | 1.042M |
| Aug 14, 2026 | 10.68 | 10.86 | 10.34 | 10.76 | 792514.0 |
| Aug 13, 2026 | 11.03 | 11.25 | 10.61 | 10.66 | 805581.0 |
| Aug 12, 2026 | 10.77 | 11.21 | 10.68 | 10.91 | 877342.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 262.51 |
| Capricor Therapeutics, Inc. | 8.56 |
| United Therapeutics Corp. | 498.48 |
| Ardelyx, Inc. | 3.39 |
| Biomea Fusion, Inc. | 1.74 |
Price Related Metrics
| PS Ratio | 2.388 |
| PEG Ratio | -0.2278 |
| Price to Book Value | 6.023 |
| Earnings Yield | -47.43% |
| Market Cap | 432.23M |
| PEGY Ratio | -0.2278 |